Biotia
Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs
Nuovi round di finanziamento delle startup dai moduli D della SEC e dalle notizie tech. 296 round tracciati, aggiornato il 15 ott 2026.
Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs
Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases
Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds
Tiny Health Raises $33M To Explore What Gut Data Can Reveal About Future Health
Modulo D: $5.46M collocati su un’offerta di $6.02M · 5 investitori